eXIthera Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch eXIthera Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients (NCT05040776) | eXIthera Pharmaceuticals | 2023-10-01 |
Track eXIthera Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.